USX:BMXMF - bioMérieux S.A (USD 163.2) bioMérieux S.A
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 163.2    -4.940 (-2.94%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

14 Aug 2020


Overview

14 Aug 2020

Day Change: -4.940 (-2.94%)

52 Wk Range: 60.5 - 168.14

Day's Range: 163.2 - 166.8

Last Volume: 301

Current Yield: 0.13%

Projected Yield: 0.13%

Open: USD 166.75

14 Aug 2020

Metric BMXMF S.Median
Beta 0.11 0.41
VaR 53.59 53.4
E.Shortfall 114.6 88.57
Liquidity 192.75 1,565.11

Fundamental


PE: NA

Market Cap: NA

Price Over Book: NA

Price Over Sales: NA

Return On Assets: NA

Return On Equity: NA

Current Ratio: NA

General

CEO: Mr. Alexandre Mérieux

Headquarters: US

Employees: 12,000

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

bioMérieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc. It also provides molecular biology for the detection of genetic sequences of deoxyribonucleic acid or ribonucleic acid; and companion diagnostic test based on biomarkers, as well as services for clinical and industrial laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is based in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.